Sunday, 19 May 2019

Zydus gets USFDA approval for hypertension drug

13 March 2019 | News

It works by blocking the action of certain natural chemicals in your body, such as epinephrine on the heart and blood vessels

Zydus Cadila has received the final approval from the USFDA to market Atenolol and Chlorthalidone Tablets USP (US RLD – Tenoretic®), 50 mg/25 mg and 100 mg/25 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

This medication is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. Atenolol belongs to a class of drugs known as beta blockers.

It works by blocking the action of certain natural chemicals in your body, such as epinephrine on the heart and blood vessels. This effect lowers the heart rate, blood pressure and strain on the heart. Chlorthalidone is a ‘water pill’ (diuretic) and causes the body to get rid of extra salt and water.

It also helps to relax the blood vessels so that blood can flow easily. The group now has 253 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account